Investment

SSG MedTech Fund 2024 is an innovative investment initiative designed to accelerate advancements in medical technology by supporting early-stage startups at the cutting edge of healthcare solutions. With a particular focus on transformative applications of artificial intelligence (AI) in MedTech, SSG MedTech Fund 2024 aims to empower pioneering companies whose technologies have the potential to significantly enhance patient outcomes, optimize medical processes, and address critical healthcare challenges worldwide. Inspired by successful models like the Boston Angel Club, SSG MedTech Fund 2024 builds on Sani-Med’s industry expertise, regulatory knowledge, and network of world-class research institutions to provide startups with the necessary resources, mentorship, and capital.

​

Investment Areas

• Healthcare AI: Investments in this area target AI solutions that streamline diagnostics, enhance predictive analytics, and support real-time patient management. By improving diagnostic accuracy and efficiency, these solutions enable healthcare providers to deliver proactive, data-driven care that improves patient outcomes.

• Biotech and Life Sciences: This sector emphasizes startups that use AI for drug discovery, genomics, and personalized medicine. These technologies hold the potential to accelerate therapeutic development, allowing for more precise treatments and addressing diseases on an individual level.

• Digital Health Platforms: Supporting digital platforms that enhance healthcare accessibility and provide data-driven insights, we back companies developing telemedicine, remote monitoring, and AI-enabled patient care applications. These solutions expand access to healthcare while offering personalized recommendations that empower patients in their health journeys.